PRESS RELEASE published on 06/12/2025 at 08:30, 1 year ago Oxurion avance dans l'acquisition projetée d'Axiodis Oxurion NV lève la condition suspensive relative au droit d'information préalable des salariés, avançant vers l'acquisition d'Axiodis CRO. Discussions en cours pour créer des synergies stratégiques. Oxurion se concentre sur la finalisation de l'opération Acquisition Biopharmaceutique Donnée Clinique Oxurion NV Synergies Stratégiques
PRESS RELEASE published on 06/12/2025 at 08:30, 1 year ago Oxurion moves forward with the planned acquisition of Axiodis Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
PRESS RELEASE published on 06/12/2025 at 08:30, 1 year ago Oxurion boekt vooruitgang met de voorgenomen overname van Axiodis Oxurion NV meldet die Erfüllung der aufschiebenden Bedingung hinsichtlich des Informations- und Konsultationsrechts der Arbeitnehmer für die Übernahme von Axiodis CRO. Oxurion konzentriert sich auf die Fertigstellung der Transaktion und beschleunigt Gespräche mit anderen strategischen Zielen zur Schaffung von Synergien in der Region Toulouse Übernahme Toulouse Oxurion NV Synergien Axiodis CRO
BRIEF published on 06/11/2025 at 18:05, 1 year ago Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
BRIEF published on 06/11/2025 at 18:05, 1 year ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/11/2025 at 18:00, 1 year ago Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgevingen met betrekking tot aankoop en verkoop van aandelen. Biofarmaceutisch bedrijf in Leuven, België. Meer informatie op www.oxurion.com Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Aankoop Aandelen Verkoop Aandelen
PRESS RELEASE published on 06/11/2025 at 18:00, 1 year ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications regarding share holdings from Atlas Special Opportunities II, LLC, impacting threshold percentages Share Holdings Oxurion NV Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC
BRIEF published on 06/04/2025 at 18:05, 1 year ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Atlas Special Opportunities Notification De Transparence Oxurion Législation Belge
BRIEF published on 06/04/2025 at 18:05, 1 year ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Legislation
PRESS RELEASE published on 06/04/2025 at 18:00, 1 year ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en blijft onder drempel van 5%. Bedrijf combineert therapeutische innovatie met technologieën in klinisch onderzoek Transparantiekennisgeving Aandelen Oxurion NV Biofarmaceutisch Innovatie
Published on 06/22/2026 at 23:25, 2 hours 3 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 2 hours 23 minutes ago Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 4 hours 23 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 5 hours 43 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 9 hours 30 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 21:07, 4 hours 21 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 4 hours 38 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 4 hours 56 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 6 hours 1 minute ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 6 hours 34 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:00, 7 hours 28 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION